IsoniazidAntitubercular AgentsRifampinMycobacterium tuberculosisPyrazinamideEthambutolAntibiotics, AntitubercularTuberculosis, Multidrug-ResistantTuberculosisTuberculosis, PulmonaryEthionamidePractice Guidelines as TopicStreptomycinMicrobial Sensitivity TestsDrug Therapy, CombinationAminosalicylic AcidsAminosalicylic AcidDrug Resistance, BacterialHealth Planning GuidelinesTreatment OutcomeDrug Administration ScheduleIsonicotinic AcidsGuidelines as TopicCatalaseEvidence-Based MedicineUnited StatesThioacetazoneTime FactorsGuideline AdherenceMycobacteriumMycolic AcidsDrug Resistance, Multiple, BacterialDrug Resistance, MicrobialLatent TuberculosisAza CompoundsPatient ComplianceAdvisory CommitteesHIV InfectionsSputumTuberculin TestMycobacteriophagesBacterial ProteinsSocieties, MedicalColony Count, MicrobialClofazimineRifamycinsAntineoplastic Combined Chemotherapy ProtocolsClinical Trials as TopicConsensusAnti-Bacterial AgentsMycobacterium smegmatisArylamine N-AcetyltransferaseHydrazinesOxidoreductasesQuinolinesDirectly Observed TherapyRetrospective StudiesRisk FactorsDrug-Induced Liver InjuryMass ScreeningDiarylquinolinesProspective StudiesSouth AfricaTuberculosis, Meningeal